Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  misonidazole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 61 for your search:
Start Over
Phase II/III Evaluation of Intraoperative Radiotherapy and Adjuvant Chemotherapy with CAM (CTX/ADR/MTX) for Nonmetastatic Soft Tissue Retroperitoneal Sarcoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 10 to 65
Sponsor: NCI
Protocol IDs: NCI-80-C-45, NCI-SB-S9, NCI-T83-1103N, T83-1103
Phase III Surgery plus Intraoperative Radiotherapy with Radiosensitization plus External Beam Radiotherapy and Chemotherapy for Localized Resectable and Nonresectable Pancreatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-83-C-142, NCI-ROB-SB-831, NCI-T83-1238N
Phase III Large Dose/Fraction Radiotherapy and Hypoxic Cell Sensitizer Misonidazole for Advanced Carcinoma of the Uterine Cervix
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-RT8/rt60
Phase III Radiotherapy with or without Misonidazole for Locally Advanced Stage II/III/IV Squamous Cell Carcinoma of the Head and Neck
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: RTOG-7915, RTOG-79-15
Phase III Misonidazole Radiosensitization Before Radiotherapy vs Radiotherapy Alone for Brain Metastases
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: RTOG-7916
Phase III Radiotherapy vs Radiotherapy plus Misonidazole for Locally Advanced Stage III non-Oat Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: RTOG-7917, NCOG-2N801J
Phase III Chemotherapy with BCNU plus Radiotherapy with or without MNI for Malignant Glioma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: RTOG-7918, RTOG-79-18
Phase III Radiotherapy with and without Misonidazole for Locally Advanced non-Oat Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: RTOG-7925
Phase III Comparison of Radiation Alone vs Radiation plus Misonidazole in the Treatment of Liver Metastases
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: RTOG-8003, RTOG-80-03
Phase III Surgery with or without Postoperative Radiotherapy vs Surgery plus Intraoperative Radiotherapy plus MNI for Pancreatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 to 75
Sponsor:
Protocol IDs: NCI-80-C-57, NCI-ROB-801
Phase III Surgery plus Intra-operative Radiotherapy with Radiosensitization vs Surgery Alone for Adenocarcinoma of the Stomach with No Distant Metastases (Summary Last Modified 04/92)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: NCI-80-C-59, NCI-ROB-802, NCI-T83-1104N, T83-1104
Phase III Comparison of HU vs MNI as an Adjunct to Radiotherapy for Stage IIB/III/IVA Cervical Carcinoma with Negative Para-Aortic Nodes
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-56
Phase III Radiotherapy with or without Radiosensitization with MNI for Stage IIIB/IVA Squamous Cell Carcinoma of the Uterine Cervix
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: RTOG-8005
Phase III Randomized Evaluation of High-Dose Multiple Daily Fractionation Radiotherapy and MNI Radiosensitization for Grade III/IV Malignant Glioma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-22803
Phase III Randomized Trial of MNI and Two Radiotherapy Fractionation Schedules for Untreated Stage III/IV Carcinoma of the Head and Neck
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: EORTC-22811
Phase III Randomized Study of Intraoperative Radiotherapy plus Surgery in Patients with Squamous Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-84-C-251, NCI-T85-0014N, T85-0014
Phase II Radiosensitization with Misonidazole plus Radiotherapy for Recurrent Head and Neck Squamous Cell Carcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 21
Sponsor: NCI
Protocol IDs: RTOG-7802
Phase I-II Misonidazole Radiosensitization Prior to Radiotherapy for Brain Metastases in Multimetastatic Disease
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: RTOG-7812
Phase I/II Radiosensitization with Misonidazole plus Half-Body Radiotherapy for Neoplasms with Multiple Metastases
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: RTOG-7813
Phase I/II Study of Hypoxic Cell Sensitizer Misonidazole plus Radiotherapy for Locally Advanced Lung Carcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: RTOG-7814
Phase I/II Radiosensitization with Misonidazole plus Radiotherapy for Advanced Soft Tissue Sarcomas or Melanomas
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: RTOG-7815
Phase I/II Radiosensitization with Misonidazole plus Radiotherapy for Bladder Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: under 75
Sponsor: NCI
Protocol IDs: RTOG-7821
Phase I-II Misonidazole Radiosensitization Prior to Radiotherapy for Recurrent Brain Tumors in Children
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: RTOG-7823, CCG-985
Start Over